Oral administration of an easily prepared solution of injectable methotrexate diluted in water: A comparison of serum concentrations vs methotrexate tablets and clinical utility

Journal of Rheumatology

Volumn 23, Issue 3, 1996, Pages 455-458

  Marshall, Peter S ^a,c   Gertner, Elie ^b  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^c REGIONS HOSPITAL   (United States)

Author keywords

Administration; Methotrexate; Pharmacokinetics; Rheumatoid arthritis

Indexed keywords

METHOTREXATE;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG ADMINISTRATION; DRUG BLOOD LEVEL; DRUG SOLUTION; FEMALE; HUMAN; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; TABLET;

ADMINISTRATION, ORAL; ADULT; AGED; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; FEMALE; HUMANS; INDICATOR DILUTION TECHNIQUES; INJECTIONS; MALE; METHOTREXATE; MIDDLE AGED; TABLETS; WATER;

EID: 0029897764     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Weinblatt ME, Coblyn JS, Fox DA, et al.: Efficacy of low-dose methotrexate in rheumatoid arthritis. N Eng J Med 1985,312:818-22.
2. Wemblatt ME, Weissman BN, Holdsworth DE, et al.: Long-term prospective study of methotrexate in the treatment of rheumatoid arthritis. 84-month update. Arthritis Rheum 1992;35:129-37.
3. Kremer JM, Phelps CT: Long-term prospective study of the use of methotrexate in rheumatoid arthritis: Update after a mean of 90 months. Arthritis Rheum 1992;35:138-15.
4. Wolfe F, Hawley DJ, Cathey MA: Termination of slow acting antirheumatic therapy in rheumatoid arthritis: A 14-year prospective evaluation of 1017 consecutive starts. J Rheumatol 1990;17:994-1002.
5. Felson DT, Anderson JJ, Meenan RF: The comparative efficacy and toxicity of second-line agents in rheumatoid arthritis Results of two metaanalyses. Arthritis Rheum 1990;33:1449-61.
6. McLaughlin GE: Parenteral versus oral methotrexate: A cost comparison (letter) Arthritis Rheum 1994;37.779.
7. Wase LC: Parenteral versus oral methotrexate (reply to letter). Arthritis Rheum 1994:37:779.
8. Jundt JW, Browne BA, Fiocco GP, Steele AD, Mock D: A comparison of low dose methotrexate bioavailability: Oral solution, oral tablet, subcutaneous and intramuscular dosing. J Rheumatol 1993;20:1845-9
9. Stuart JFB, Calman KC, Watters J, et al.: Bioavailability of methotrexate: Implications for clinical use. Cancer Chemother Pharmacol 1979;3:239-41.
10. Arnett FC, Edworthy SM, Bloch DA, et al.: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
11. Rooney TW, Furst DE: Methotrexate. In: McCarty D, Koopman W, eds. Arthritis and Allied Conditions. A Textbook of Rheumatology. 12th ed, vol. 1. Philadelphia: Lea and Febiger, 1993:621-36.
12. Swanson HJ: Cost and handling of parenteral methotrexate (letter). Arthritis Rheum 1995;38:575.
13. Hanson DL: Cost effectiveness of orally administered liquid methotrexate: Comment on the letters by McLaughlin and by Wase (letter). Arthritis Rheum 1994;37:1713.
14. Hunt RE, Shergy WJ, Phillips RM Jr: Alternative forms of methotrexate. Arthritis Rheum 1992;(suppl)35:S149.
15. Oguey D, Kolliker F, Gerber NJ, Reichen J: Effect of food on the bioavailability of low-dose methotrexate in patients with rheumatoid arthritis. Arthritis Rheum 1992;35:611-4.
16. Hamilton RA, Kremer JM: The effects of food on methotrexate absorption. J Rheumatol 1995;22:630-2.
17. Steele W, Stuart JFB, Lawrence JR, et al.: Enhancement of methotrexate absorption by subdivision of dose. Cancer Chemother Pharmacol 1979;3:235-7.
18. Harvey VG, Slevin ML, Woollard RC, et al.: The bioavailability of oral intermediate-dose methotrexate: Effect of dose subdivision, formulation, and timing in the chemotherapy cycle. Cancer Chemother Pharmacol 1984;13:91-4.
19. Wright MP, Newton JM: Stability of methotrexate injection in prefilled. plastic disposable syringes. Int J Pharmaceut 1988;45:237-44.
20. Hunt PG, Rose CD, Smith C: Parenteral methotrexate: Effective shelf-life following initial puncture of preservative-protected vial (letter). Arthritis Rheum 1995;38:575.